$GILD Recent News Does Jersey’s lagging econ
Post# of 89346
Posted On: 01/29/2015 12:10:36 PM
$GILD Recent News
Does Jersey’s lagging economy doom Christie’s bid? 8:31 a.m. Jan. 26, 2015 - Tim Mullaney
Don’t look for pricey hepatitis drugs to come down 2:32 p.m. Jan. 13, 2015 - Russ Britt
Three investments to own and three to 6:00 a.m. Jan. 13, 2015 - Howard Gold
Wynn, Newmont lead gainers; Macy’s, Bed Bath & Beyond slump 11:05 a.m. Jan. 9, 2015 - Sue Chang
Fifteen stocks for 2015, part 1 10:36 a.m. Jan. 9, 2015 - The Trading Deck
AbbVie predicts sharp increase in earnings 4:56 p.m. Jan. 8, 2015 - MarketWatch.com
Gilead Sciences shares rise 2.4% 9:32 a.m. Jan. 6, 2015 - Sue Chang
Gilead to buy liver disease treatment from Germany's Phenex 8:39 a.m. Jan. 6, 2015 - Ciara Linnane
Gilead, CVS strike deal on Hepatitis C drugs 1:47 p.m. Jan. 5, 2015 - Russ Britt
Eight charts plot the year in finance 12:45 p.m. Dec. 30, 2014 - Ophir Gottlieb
Are consumers getting gouged on health care? 9:35 a.m. Dec. 30, 2014 - Russ Britt
S&P 500 rises to record, but Dow snaps 7-day win streak 4:24 p.m. Dec. 29, 2014 - Sara Sjolin
Manitowoc, Gilead climb; Tesla slips 11:12 a.m. Dec. 29, 2014 - Wallace Witkowski
Mon., Dec. 29, 2014: Watch Manitowoc Stock 10:32 a.m. Dec. 29, 2014 - MarketWatch
Gilead shares up 3% as Morgan Stanley upgrades to overweight 10:07 a.m. Dec. 29, 2014 - Ciara Linnane
Gilead shares up 2.9% in early trade 9:52 a.m. Dec. 29, 2014 - Ciara Linnane
Gilead upgraded to overweight from equal-weight at Morgan Stanley 9:52 a.m. Dec. 29, 2014 - Ciara Linnane
U.S. Stock Futures Fall, Following Europe's Lead 9:51 a.m. Dec. 29, 2014 - MarketWatch
Gilead Sciences, energy plays lead S&P advancers 9:34 a.m. Dec. 29, 2014 - Silvia Ascarelli
Why speculators see opportunity in younger, cyclical stocks 2:50 p.m. Dec. 26, 2014 - The Trading Deck
AbbVie - Gilead hep C battle moves to state programs 9:56 a.m. Today - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Markets Look Bad Now? They'll Get Better 8:23 p.m. Jan. 28, 2015 - TheStreet.com
States Work to Strike Deals for Hep C Drug Discounts 7:51 p.m. Jan. 28, 2015 - The Wall Street Journal Interactive Edition
Is AbbVie (ABBV) Set to Beat 4Q Earnings on Humira Sales? - Analyst Blog 5:50 p.m. Jan. 28, 2015 - Zacks.com
Can Gilead Beat AbbVie At Its Own Game? 4:18 p.m. Jan. 28, 2015 - Seeking Alpha
Biotech Stocks Down Despite Strong Amgen Quarter 2:35 p.m. Jan. 28, 2015 - Investors Business Daily
Can Regulus Therapeutics Double Again on Next Hep-C Drug Trial Update? 2:28 p.m. Jan. 28, 2015 - TheStreet.com
AmerisourceBergen Hits New High On Earnings, Outlook 12:45 p.m. Jan. 28, 2015 - Investors Business Daily
Short Sellers Starting to Gang Up on Biotech 10:22 a.m. Jan. 28, 2015 - 247WallSt.com
Gilead Includes Pan-Genotypic Agent in HCV Licensing Deals - Analyst Blog 6:55 p.m. Jan. 27, 2015 - Zacks.com
3 Stocks Dragging The Health Care Sector Downward 12:07 p.m. Jan. 27, 2015 - TheStreet.com
Do You Believe Me Now? 10:59 a.m. Jan. 27, 2015 - Seeking Alpha
Celgene: Could You Be More Like Gilead, Please? 7:47 a.m. Jan. 27, 2015 - Seeking Alpha
Gilead inks exclusive HCV deal with PBM firm 1:20 p.m. Jan. 26, 2015 - Seeking Alpha
Gilead adds investigational NS5A inhibitor to generic licensing agreements 7:12 a.m. Jan. 26, 2015 - Seeking Alpha
US Stock Futures Signal Lower Start On Wall Street 6:14 a.m. Jan. 26, 2015 - benzinga.com
Gilead to Allow Drug Makers to Produce Hepatitis C Treatment 5:07 a.m. Jan. 26, 2015 - The Wall Street Journal Interactive Edition
3 Attractive Biotech Picks For 2015 9:44 a.m. Jan. 23, 2015 - Seeking Alpha
What Lessons Has Express Scripts Taught Us? The Future For The Pharmaceutical Industry 7:30 a.m. Jan. 23, 2015 - Seeking Alpha
2014 Portfolio Review: Year One Of My DGI Journey, Part I 6:29 p.m. Jan. 22, 2015 - Seeking Alpha
Earnings Forecast Buzz for Fannie Mae, Apple, Yahoo, Alibaba, Gilead Sciences, and Bank of America 8:45 a.m. Today - PR Newswire - PRF
Gilead Announces Executive Promotions 4:30 p.m. Jan. 28, 2015 - BusinessWire - BZX
Gilead Sciences to Release Fourth Quarter and Full Year 2014 Financial Results on Tuesday, February 3, 2015 5:00 p.m. Jan. 27, 2015 - BusinessWire - BZX
EnvisionRx and Gilead Sciences Sign Exclusive Agreement to Help in the Fight Against Hepatitis C 1:00 p.m. Jan. 26, 2015 - BusinessWire - BZX
Mylan Expands Hepatitis C Licensing Agreement with Gilead to Include Investigational Pan-Genotypic Agent 10:58 a.m. Jan. 26, 2015 - PR Newswire - PRF
Earnings Forecast Research for Apple, Alibaba, FXCM, Gilead Sciences, Freeport-McMoRan, and Bank of America 8:45 a.m. Jan. 26, 2015 - PR Newswire - PRF
Morningstar Names John Martin of Gilead Sciences as its 2014 CEO of the Year 1:06 p.m. Jan. 21, 2015 - PR Newswire - PRF
Critical Alerts For Mobileye NV, Kandi Technologies, Gilead Sciences, Petrobras and Noodles & Company Released By InvestorsObserver 9:31 a.m. Jan. 20, 2015 - PR Newswire - PRF
Earnings Forecast Research for Apple, Intel, Alibaba, Bank of America, Activision Blizzard, and Gilead Sciences 8:45 a.m. Jan. 20, 2015 - PR Newswire - PRF
Pharmaceutical-Bio Industry's First-Quarter 2015 Capital and Maintenance Project Starts Near $4 Billion Investment in North America, an Industrial Info News Alert 6:15 a.m. Jan. 20, 2015 - Marketwired
Earnings Forecast Research for Apple, Bank of America, Freeport-McMoRan, Agenus, Alibaba, and Sirius XM 8:45 a.m. Jan. 14, 2015 - PR Newswire - PRF
Gilead Sciences to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 5:00 p.m. Jan. 12, 2015 - BusinessWire - BZX
Reveal Earnings Forecast for Arena Pharmaceuticals, Petrobras, Alibaba, Apple, Gilead Sciences, and Applied Materials 8:45 a.m. Jan. 9, 2015 - PR Newswire - PRF
Earnings Forecast for Apple, Alibaba, Twitter, Gilead Sciences, Michael Kors, and Tesla 8:45 a.m. Jan. 7, 2015 - PR Newswire - PRF
Biotechs to Follow in 2015 off Fresh Insider Moves 10:00 a.m. Jan. 6, 2015 - ACCESSWIRE
Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases 8:31 a.m. Jan. 6, 2015 - BusinessWire - BZX
Factors Moving Markets: Complementary Reports on United Parcel Service, Gilead, Manitowoc, EMC Corporation, and LiveDeal 9:10 a.m. Dec. 30, 2014 - PR Newswire - PRF
Biotech Stocks Technical Data -- Gilead Sciences, ImmunoGen, Exelixis, Cubist Pharma, and Vanda Pharma 8:55 a.m. Dec. 30, 2014 - PR Newswire - PRF
Gilead Announces Amended Agreements With Janssen to Develop and Commercialize Tenofovir Alafenamide-Based Single Tablet Regimens for HIV Treatment 8:30 a.m. Dec. 29, 2014 - BusinessWire - BZX
Critical Alerts For Achillion Pharmaceuticals, AT&T, Peabody Energy, Gilead Sciences and Facebook Released By InvestorsObserver 9:31 a.m. Dec. 23, 2014 - PR Newswire - PRF
Does Jersey’s lagging economy doom Christie’s bid? 8:31 a.m. Jan. 26, 2015 - Tim Mullaney
Don’t look for pricey hepatitis drugs to come down 2:32 p.m. Jan. 13, 2015 - Russ Britt
Three investments to own and three to 6:00 a.m. Jan. 13, 2015 - Howard Gold
Wynn, Newmont lead gainers; Macy’s, Bed Bath & Beyond slump 11:05 a.m. Jan. 9, 2015 - Sue Chang
Fifteen stocks for 2015, part 1 10:36 a.m. Jan. 9, 2015 - The Trading Deck
AbbVie predicts sharp increase in earnings 4:56 p.m. Jan. 8, 2015 - MarketWatch.com
Gilead Sciences shares rise 2.4% 9:32 a.m. Jan. 6, 2015 - Sue Chang
Gilead to buy liver disease treatment from Germany's Phenex 8:39 a.m. Jan. 6, 2015 - Ciara Linnane
Gilead, CVS strike deal on Hepatitis C drugs 1:47 p.m. Jan. 5, 2015 - Russ Britt
Eight charts plot the year in finance 12:45 p.m. Dec. 30, 2014 - Ophir Gottlieb
Are consumers getting gouged on health care? 9:35 a.m. Dec. 30, 2014 - Russ Britt
S&P 500 rises to record, but Dow snaps 7-day win streak 4:24 p.m. Dec. 29, 2014 - Sara Sjolin
Manitowoc, Gilead climb; Tesla slips 11:12 a.m. Dec. 29, 2014 - Wallace Witkowski
Mon., Dec. 29, 2014: Watch Manitowoc Stock 10:32 a.m. Dec. 29, 2014 - MarketWatch
Gilead shares up 3% as Morgan Stanley upgrades to overweight 10:07 a.m. Dec. 29, 2014 - Ciara Linnane
Gilead shares up 2.9% in early trade 9:52 a.m. Dec. 29, 2014 - Ciara Linnane
Gilead upgraded to overweight from equal-weight at Morgan Stanley 9:52 a.m. Dec. 29, 2014 - Ciara Linnane
U.S. Stock Futures Fall, Following Europe's Lead 9:51 a.m. Dec. 29, 2014 - MarketWatch
Gilead Sciences, energy plays lead S&P advancers 9:34 a.m. Dec. 29, 2014 - Silvia Ascarelli
Why speculators see opportunity in younger, cyclical stocks 2:50 p.m. Dec. 26, 2014 - The Trading Deck
AbbVie - Gilead hep C battle moves to state programs 9:56 a.m. Today - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Markets Look Bad Now? They'll Get Better 8:23 p.m. Jan. 28, 2015 - TheStreet.com
States Work to Strike Deals for Hep C Drug Discounts 7:51 p.m. Jan. 28, 2015 - The Wall Street Journal Interactive Edition
Is AbbVie (ABBV) Set to Beat 4Q Earnings on Humira Sales? - Analyst Blog 5:50 p.m. Jan. 28, 2015 - Zacks.com
Can Gilead Beat AbbVie At Its Own Game? 4:18 p.m. Jan. 28, 2015 - Seeking Alpha
Biotech Stocks Down Despite Strong Amgen Quarter 2:35 p.m. Jan. 28, 2015 - Investors Business Daily
Can Regulus Therapeutics Double Again on Next Hep-C Drug Trial Update? 2:28 p.m. Jan. 28, 2015 - TheStreet.com
AmerisourceBergen Hits New High On Earnings, Outlook 12:45 p.m. Jan. 28, 2015 - Investors Business Daily
Short Sellers Starting to Gang Up on Biotech 10:22 a.m. Jan. 28, 2015 - 247WallSt.com
Gilead Includes Pan-Genotypic Agent in HCV Licensing Deals - Analyst Blog 6:55 p.m. Jan. 27, 2015 - Zacks.com
3 Stocks Dragging The Health Care Sector Downward 12:07 p.m. Jan. 27, 2015 - TheStreet.com
Do You Believe Me Now? 10:59 a.m. Jan. 27, 2015 - Seeking Alpha
Celgene: Could You Be More Like Gilead, Please? 7:47 a.m. Jan. 27, 2015 - Seeking Alpha
Gilead inks exclusive HCV deal with PBM firm 1:20 p.m. Jan. 26, 2015 - Seeking Alpha
Gilead adds investigational NS5A inhibitor to generic licensing agreements 7:12 a.m. Jan. 26, 2015 - Seeking Alpha
US Stock Futures Signal Lower Start On Wall Street 6:14 a.m. Jan. 26, 2015 - benzinga.com
Gilead to Allow Drug Makers to Produce Hepatitis C Treatment 5:07 a.m. Jan. 26, 2015 - The Wall Street Journal Interactive Edition
3 Attractive Biotech Picks For 2015 9:44 a.m. Jan. 23, 2015 - Seeking Alpha
What Lessons Has Express Scripts Taught Us? The Future For The Pharmaceutical Industry 7:30 a.m. Jan. 23, 2015 - Seeking Alpha
2014 Portfolio Review: Year One Of My DGI Journey, Part I 6:29 p.m. Jan. 22, 2015 - Seeking Alpha
Earnings Forecast Buzz for Fannie Mae, Apple, Yahoo, Alibaba, Gilead Sciences, and Bank of America 8:45 a.m. Today - PR Newswire - PRF
Gilead Announces Executive Promotions 4:30 p.m. Jan. 28, 2015 - BusinessWire - BZX
Gilead Sciences to Release Fourth Quarter and Full Year 2014 Financial Results on Tuesday, February 3, 2015 5:00 p.m. Jan. 27, 2015 - BusinessWire - BZX
EnvisionRx and Gilead Sciences Sign Exclusive Agreement to Help in the Fight Against Hepatitis C 1:00 p.m. Jan. 26, 2015 - BusinessWire - BZX
Mylan Expands Hepatitis C Licensing Agreement with Gilead to Include Investigational Pan-Genotypic Agent 10:58 a.m. Jan. 26, 2015 - PR Newswire - PRF
Earnings Forecast Research for Apple, Alibaba, FXCM, Gilead Sciences, Freeport-McMoRan, and Bank of America 8:45 a.m. Jan. 26, 2015 - PR Newswire - PRF
Morningstar Names John Martin of Gilead Sciences as its 2014 CEO of the Year 1:06 p.m. Jan. 21, 2015 - PR Newswire - PRF
Critical Alerts For Mobileye NV, Kandi Technologies, Gilead Sciences, Petrobras and Noodles & Company Released By InvestorsObserver 9:31 a.m. Jan. 20, 2015 - PR Newswire - PRF
Earnings Forecast Research for Apple, Intel, Alibaba, Bank of America, Activision Blizzard, and Gilead Sciences 8:45 a.m. Jan. 20, 2015 - PR Newswire - PRF
Pharmaceutical-Bio Industry's First-Quarter 2015 Capital and Maintenance Project Starts Near $4 Billion Investment in North America, an Industrial Info News Alert 6:15 a.m. Jan. 20, 2015 - Marketwired
Earnings Forecast Research for Apple, Bank of America, Freeport-McMoRan, Agenus, Alibaba, and Sirius XM 8:45 a.m. Jan. 14, 2015 - PR Newswire - PRF
Gilead Sciences to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 5:00 p.m. Jan. 12, 2015 - BusinessWire - BZX
Reveal Earnings Forecast for Arena Pharmaceuticals, Petrobras, Alibaba, Apple, Gilead Sciences, and Applied Materials 8:45 a.m. Jan. 9, 2015 - PR Newswire - PRF
Earnings Forecast for Apple, Alibaba, Twitter, Gilead Sciences, Michael Kors, and Tesla 8:45 a.m. Jan. 7, 2015 - PR Newswire - PRF
Biotechs to Follow in 2015 off Fresh Insider Moves 10:00 a.m. Jan. 6, 2015 - ACCESSWIRE
Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases 8:31 a.m. Jan. 6, 2015 - BusinessWire - BZX
Factors Moving Markets: Complementary Reports on United Parcel Service, Gilead, Manitowoc, EMC Corporation, and LiveDeal 9:10 a.m. Dec. 30, 2014 - PR Newswire - PRF
Biotech Stocks Technical Data -- Gilead Sciences, ImmunoGen, Exelixis, Cubist Pharma, and Vanda Pharma 8:55 a.m. Dec. 30, 2014 - PR Newswire - PRF
Gilead Announces Amended Agreements With Janssen to Develop and Commercialize Tenofovir Alafenamide-Based Single Tablet Regimens for HIV Treatment 8:30 a.m. Dec. 29, 2014 - BusinessWire - BZX
Critical Alerts For Achillion Pharmaceuticals, AT&T, Peabody Energy, Gilead Sciences and Facebook Released By InvestorsObserver 9:31 a.m. Dec. 23, 2014 - PR Newswire - PRF
(0)
(0)